Used in cancer research, particularly in studies focused on overcoming multidrug resistance in tumor cells. It shows potential as a microtubule-stabilizing agent, similar to paclitaxel, but with modified activity due to the N-methyl group. This modification can influence cellular uptake and retention, making it a candidate for evaluating structure-activity relationships in taxane derivatives. Investigated for its cytotoxic effects against various cancer cell lines, especially in efforts to improve chemotherapeutic efficacy and reduce resistance mechanisms.